These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31622620)

  • 61. Opportunities to improve colorectal cancer screening in Connecticut through Medicare claims data.
    Van Hoof TJ; Ho SY; Curry M; Gacek P; Brooks AH; Meehan TP
    Conn Med; 2011 Feb; 75(2):69-82. PubMed ID: 21476376
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
    Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Sarfati D; Greuter MJE; Coupé VMH; Canfell K
    Int J Cancer; 2018 Jul; 143(2):269-282. PubMed ID: 29441568
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Review of the Cervical Cancer Burden and Population-Based Cervical Cancer Screening in China.
    Di J; Rutherford S; Chu C
    Asian Pac J Cancer Prev; 2015; 16(17):7401-7. PubMed ID: 26625735
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidemiology and screening of colorectal cancer.
    Faivre J; Bouvier AM; Bonithon-Kopp C
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):187-99. PubMed ID: 11969233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies.
    Black A; Huang WY; Wright P; Riley T; Mabie J; Mathew S; Ragard L; Hermansen S; Yu K; Pinsky P; Prorok PC; Freedman ND; Hoover RN
    Rev Recent Clin Trials; 2015; 10(3):238-45. PubMed ID: 26435289
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Screening and surveillance for colorectal cancer.
    Markowitz AJ; Winawer SJ
    Semin Oncol; 1999 Oct; 26(5):485-98. PubMed ID: 10528896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fostering partnerships and program success.
    Phillips-Angeles E; Song L; Hannon PA; Celedonia M; Stearns S; Edwards K; Feest S; Shumann A
    Cancer; 2013 Aug; 119 Suppl 15():2884-93. PubMed ID: 23868483
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Challenges to the adoption of risk algorithms for colorectal cancer screening programmes: perspectives for future research.
    Huang JJ; Huang JL
    Hong Kong Med J; 2017 Dec; 23(6):661-3. PubMed ID: 29226840
    [No Abstract]   [Full Text] [Related]  

  • 69. Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice.
    Levin TR
    Am J Gastroenterol; 2017 Jan; 112(1):8-10. PubMed ID: 27801886
    [No Abstract]   [Full Text] [Related]  

  • 70. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial.
    De Mil R; Guillaume E; Guittet L; Dejardin O; Bouvier V; Pornet C; Christophe V; Notari A; Delattre-Massy H; De Seze C; Peng J; Launoy G; Berchi C
    Value Health; 2018 Jun; 21(6):685-691. PubMed ID: 29909873
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Seasonal flu vaccines advancing the delivery of colorectal cancer screening.
    Potter M
    S D Med; 2013; Spec no():133. PubMed ID: 23444605
    [No Abstract]   [Full Text] [Related]  

  • 72. Colonoscopic findings in first-degree relatives of patients with colorectal cancer: a population-based screening program.
    Armelao F; Paternolli C; Franceschini G; Franch R; Orlandi PG; Miori G; Avancini I; Togni M; Rossi M; Meggio A; Tasini E; Manfrini R; Giacomin D; Fasoli R; Faitini K; Mastromauro M; Costa S; Ridolfi F; Rosi P; de Pretis G
    Gastrointest Endosc; 2011 Mar; 73(3):527-534.e2. PubMed ID: 21353850
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Interpretation of global colorectal cancer statistics].
    Zheng Y; Wang ZZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):149-152. PubMed ID: 33503712
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [On prevention and control strategy of colorectal cancer in China].
    Chen HD; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1627-1632. PubMed ID: 33297618
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Realizing the need for colorectal cancer screening in Pakistan.
    Muhammad SZ; Fatima N
    J Pak Med Assoc; 2020 Jul; 70(7):1309. PubMed ID: 32799305
    [No Abstract]   [Full Text] [Related]  

  • 76. Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies.
    Autier P; Sullivan R
    J Glob Oncol; 2019 Feb; 5():1-5. PubMed ID: 30715958
    [No Abstract]   [Full Text] [Related]  

  • 77. Inequalities in colorectal cancer screening uptake.
    Berstad P; Schult AL; Hoff G; Ursin G; Randel KR
    Tidsskr Nor Laegeforen; 2023 Mar; 143(5):. PubMed ID: 36987894
    [No Abstract]   [Full Text] [Related]  

  • 78. Improving global digestive health: the gastroenterologists' role.
    Chudy-Onwugaje K; von Rosenvinge EC
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):882-883. PubMed ID: 32941831
    [No Abstract]   [Full Text] [Related]  

  • 79. The average-risk age threshold for colorectal cancer screening: should it be lowered?
    Imperiale TF
    Dig Dis Sci; 2011 May; 56(5):1249-51. PubMed ID: 21360278
    [No Abstract]   [Full Text] [Related]  

  • 80. The global challenge of colorectal cancer.
    Guren MG
    Lancet Gastroenterol Hepatol; 2019 Dec; 4(12):894-895. PubMed ID: 31648973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.